Search Results 161-170 of 822 for ���������������������������������������������:PC90���

  1. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

    A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in ...

  2. A Study of the Safety and Effectiveness of QPI-1002 for the Prevention of Delayed Graft Function in Transplant Recipients from Older Kidney Donors who have Died - Mayo Clinic

    The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function when using QPI-1002 with kidney transplants from ...

  3. Mobile and Remote Monitoring of Seating Pressure for Wheelchair Users With SCI - Mayo Clinic

    The purpose of this study is to gather information on how a mobile pressure mapping system, when used at home on a daily basis, affects behaviors known to ...

  4. Study of Cisplatin-Induced Peripheral Neuropathy in Patients with Germ Cell Tumor - Mayo Clinic

    The purpose of this study is to investigate the incidence, characteristics of, and changes in chronic neuropathy symptoms related to cisplatin and evaluate the ...

  5. Mayo Clinic Minute: What is a 'brain pacemaker?' VIDEO AUDIO Dr. Zimmerman "It's kind of like a pacemaker for the heart, bu

    "It's kind of like a pacemaker for the heart, but instead, we use it for the brain." Mayo Clinic neurosurgeon Dr. Richard Zimmerman.

  6. PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL) (PACIFICA) - Mayo Clinic

    PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera ...

  7. A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Systemic Synuclein Sampling Study (S4) - Mayo Clinic

    About this study. The purpose of this study is to measure alpha-synuclein in peripheral body tissues and fluids in Parkinson's disease (PD).

  10. Brain & Central Nervous System Cancers - Personalized Care for Each Patient - Mayo Clinic

    Share · Tweet . VID-20440753. Home; Brain & Central Nervous System Cancers - Personalized Care for Each Patient. Fuel groundbreaking medical research!